-
2020In 2020
Our company aligned production with international standards.
-
2019In 2019
We obtained the medical device registration certificates(NMPA) for?Duplex Real-Time PCR Diagnostic Kit for Rapid Detection of Influenza Viruse A and?Influenza Viruse B (PCR fluorescent probe method) [Certified No.?20193400251], Real-Time PCR Kit for Detection of Human Enterovirus (PCR fluorescent probe method)?[Certified No.?20193400846] and Multiple Real-Time PCR Kit for Detection of Coxsackievirus A16 and Human Enterovirus 71 (PCR fluorescent probe method) [Certified No. 20193400784].
-
2018In 2018
We obtained the ISO13485 certification and were accredited as the "Technology R&D Center of Changping District, Beijing", with our market share ranking the 2nd nationwide in the same year.
-
2017In 2017
Our company passed the ISO 13485 (Medical device-Quality management system-requirements for regulatory);
-
2016In 2016
We obtained the Class III Medical Device Business License and the Class II Medical Device Business Filing Certificate. Three of our products have successively won the Excellent Award for New Products and New Technologies of Beijing, namely the Multiplex PCR Detection System for Foodborne Pathogens (MPS), the Detection Kit for 14 Foodborne Pathogens, and the Yersinia Enterocolitica Detection Kit.
-
2015In 2015
We were selected as a "Gazelle Enterprise" and listed as the "Patent Application Pilot Center of Beijing";
-
2013In 2013
We were awarded the "High Tech Enterprise";
-
2012In 2012
The first PCR multiplex product (five enteropathogenic Escherichia coli?detection kits) came out; in the same year, we were endowed with the “High Tech Enterprise of Zhongguancun”;
-
2010In 2010
X-ABT was established;
-
2021In 2021
Our MP Workshop (approx. 10,000 m2) and 24/7 cold chain warehouse have been officially launched.
-
2022In 2022
A variety of nucleic acid testing products have obtained EU CE certification, and our automated testing system has been industrialized.
-
2023In 2023
We usher in a new era of precision fungal detection! PCR-based Fungal Triple Assay Kit was approved for marketing.
-
2024In 2024
We launched three new test kits (HAP Bacteria Triple Assay, Mycoplasma Pneumoniae & Bordetella Pertussis Assay, Aspergillus Single-target Nucleic Acid Assay).
-
2025In 2025
We have enriched our product portfolio with respiratory test kits and CAP & HAP nucleic acid test kits.

